Protagonist Therapeutics, Inc Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Protagonist Therapeutics, Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Protagonist Therapeutics, Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $696K, a 3.26% increase year-over-year.
  • Protagonist Therapeutics, Inc annual Operating Lease, Payments for 2023 was $2.74M, a 3.08% increase from 2022.
  • Protagonist Therapeutics, Inc annual Operating Lease, Payments for 2022 was $2.66M, a 29.9% increase from 2021.
  • Protagonist Therapeutics, Inc annual Operating Lease, Payments for 2021 was $2.05M, a 5.56% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $696K +$22K +3.26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $674K +$20K +3.06% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $654K +$163K +33.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $491K +$14K +2.94% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $477K +$14K +3.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $463K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.